» Articles » PMID: 25210070

Evaluation of the Alere I Influenza A&B Nucleic Acid Amplification Test by Use of Respiratory Specimens Collected in Viral Transport Medium

Overview
Specialty Microbiology
Date 2014 Sep 12
PMID 25210070
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

The Alere i Influenza A&B assay is a newly developed rapid molecular assay which has the potential to generate results within 15 min from sample collection. In this study, we evaluated the Alere i Influenza A&B assay by using salvaged frozen respiratory specimens that were collected in viral transport medium from children ages 10 months to 19 years. Alere i Influenza A&B assay test results were compared with viral culture and ProFlu(+) real-time reverse transcription-PCR (RT-PCR) assay results. We found that the overall sensitivity and specificity of the Alere i Influenza A&B assay were 93.3% and 94.5% for the detection of influenza A virus and 100% and 100% for the detection of influenza B virus, respectively, compared to viral culture. In comparison to ProFlu(+) real-time RT-PCR, overall sensitivity and specificity of the Alere i Influenza A&B assay for the detection of influenza A virus were 88.8% and 98.3% and 100% and 100% for detecting influenza B virus. Overall, the Alere i Influenza A&B assay performed well compared to either virus cell culture or RT-PCR.

Citing Articles

Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza Vaccine.

Cowling B, Okoli G Drugs. 2024; 84(9):1013-1023.

PMID: 39167316 PMC: 11438668. DOI: 10.1007/s40265-024-02083-8.


Nucleic Acid-Based Sensing Techniques for Diagnostics and Surveillance of Influenza.

Courtney S, Stromberg Z, Kubicek-Sutherland J Biosensors (Basel). 2021; 11(2).

PMID: 33673035 PMC: 7918464. DOI: 10.3390/bios11020047.


Comparison of detection rate of 16 sampling methods for respiratory viruses: a Bayesian network meta-analysis of clinical data and systematic review.

Hou N, Wang K, Zhang H, Bai M, Chen H, Song W BMJ Glob Health. 2020; 5(11).

PMID: 33168521 PMC: 7654123. DOI: 10.1136/bmjgh-2020-003053.


The impact of point-of-care testing for influenza A and B on patient flow and management in a medical assessment unit of a general hospital.

OConnell S, Conlan C, Reidy M, Stack C, Mulgrew A, Baruah J BMC Res Notes. 2020; 13(1):143.

PMID: 32156298 PMC: 7063764. DOI: 10.1186/s13104-020-04986-7.


Comparison of the ID Now Influenza A & B 2, Cobas Influenza A/B, and Xpert Xpress Flu Point-of-Care Nucleic Acid Amplification Tests for Influenza A/B Virus Detection in Children.

Kanwar N, Michael J, Doran K, Montgomery E, Selvarangan R J Clin Microbiol. 2020; 58(3).

PMID: 31941689 PMC: 7041562. DOI: 10.1128/JCM.01611-19.


References
1.
Welliver R . Respiratory syncytial virus and other respiratory viruses. Pediatr Infect Dis J. 2003; 22(2 Suppl):S6-10; discussion S10-2. DOI: 10.1097/01.inf.0000053880.92496.db. View

2.
Ribes J, Seabolt J, Overman S . Performance characteristics of VIDAS and directigen respiratory syncytial virus (RSV) antigen detection assays and culture for the identification of RSV in respiratory specimens. J Clin Microbiol. 2002; 40(5):1818-20. PMC: 130936. DOI: 10.1128/JCM.40.5.1818-1820.2002. View

3.
Molinari N, Ortega-Sanchez I, Messonnier M, Thompson W, Wortley P, Weintraub E . The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007; 25(27):5086-96. DOI: 10.1016/j.vaccine.2007.03.046. View

4.
. Performance of rapid influenza diagnostic tests during two school outbreaks of 2009 pandemic influenza A (H1N1) virus infection - Connecticut, 2009. MMWR Morb Mortal Wkly Rep. 2009; 58(37):1029-32. View

5.
Peaper D, Landry M . Rapid diagnosis of influenza: state of the art. Clin Lab Med. 2014; 34(2):365-85. PMC: 7172071. DOI: 10.1016/j.cll.2014.02.009. View